Filter by:
Topic
Resource Type
Audience
Display Only
Showing 136 Results
E.V.I.dently® | August 2022
In this issue: Evidence and drug pricing policy, wages and access to care, the (minimal) costs of expanding pre-deductible coverage.
E.V.I.dently® | May 2022
In this issue: Improving benefit design, patient perspectives on innovation, resources to guide health spending research and policy-making & more.
E.V.I.dently® | March 2022
In this issue: Measuring the impact of innovation, new resources to navigate health spending research and policy-making, good practices for HDHPs and a busy spring event calendar.
Employers Identify Best Practices for High-Deductible Health Plans in New Research From the National Pharmaceutical Council and Gallagher Research & Insights
Webinar highlights new research and steps employers can take to implement better HDHP designs.
E.V.I.dently® | January 2022
In this issue: We offer a new resource on the myth of the "average" patient, outline key challenges in value assessment and health technology assessment, and highlight two upcoming webinars.
National Pharmaceutical Council Appoints Dr. Sharon Phares as Chief Scientific Officer
NPC announced the appointment of Sharon Phares, PhD, MPH, as Chief Scientific Officer.
E.V.I.dently® | November 2021
In this issue: Explore the pitfalls in the most recent drug pricing deal, regulation that's led to improvements in employee benefits and keys to improving equity in health coverage.
Mallinckrodt’s Steven Romano Elected National Pharmaceutical Council Board Chair
NPC announced Steven Romano, MD, Executive Vice President and Chief Scientific Officer, Mallinckrodt Pharmaceuticals, has been elected Chair of NPC’s Board of Directors for 2021-2022.
E.V.I.dently® | September 2021
In this issue: Explore drug pricing and innovation, patient input in health benefit design, the research infrastructure to examine social determinants of health and upcoming events.
NPC Commits to Mandating COVID-19 Vaccination
NPC joined a group of 14 health care organizations in and around Washington, D.C., in issuing a joint statement making COVID-19 vaccination a condition of returning to work in their respective…
E.V.I.dently® - July 2021
In this issue: meet NPC's new president and CEO, learn how we can tackle low-value care, what we need to know about the budget cap dilemma, and catch up on news you might have missed!
National Pharmaceutical Council Appoints John M. O’Brien as President and CEO
Veteran drug pricing and health policy expert John M. O’Brien, Pharm.D., MPH, has been appointed as president and chief executive officer of the National Pharmaceutical Council, effective June 1,…
The American Journal of Managed Care® Adds National Pharmaceutical Council to Strategic Alliance Partnership Program
The American Journal of Managed Care® (AJMC®) and Pharmacy Times® today announced that the National Pharmaceutical Council (NPC) has joined their Strategic Alliance Partnership (SAP) programs.
E.V.I.dently October 2020
This month marks the last time you’ll see E.V.I.dently® in its current format and layout. That’s because we’re working on some exciting changes to our e-newsletters and website, with an eye toward…
National Pharmaceutical Council Names Dr. Robert Dubois as Interim President and CEO
As interim president and CEO, Dr. Robert Dubois plans to focus on two priorities: continuing to leverage NPC's ongoing evidence-based research, partnerships and education, and preparing for future…
NPC Announces Departure of President and CEO Dan Leonard
Dan Leonard is leaving as head of the National Pharmaceutical Council, effective Sept. 4.